Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.86 USD | +4.38% | +8.95% | -11.73% |
May. 07 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q1 Revenue $966,000 | MT |
Financials (USD)
Sales 2024 * | 4.54M | Sales 2025 * | 2.75M | Capitalization | 99.06M |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | -67M | EV / Sales 2024 * | 21.8 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 36 x |
P/E ratio 2024 * |
-1.5
x | P/E ratio 2025 * |
-2.2
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.72% |
1 day | +4.38% | ||
1 week | +8.95% | ||
Current month | +5.15% | ||
1 month | -7.48% | ||
3 months | -21.64% | ||
6 months | +5.54% | ||
Current year | -11.73% |
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 23-07-10 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-25 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-02-11 | |
Joseph Patti
BRD | Director/Board Member | 60 | 19-05-08 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 2.86 | +4.38% | 29,043 |
24-06-11 | 2.74 | +3.40% | 4,380 |
24-06-10 | 2.65 | -2.57% | 22,856 |
24-06-07 | 2.72 | +5.84% | 6,261 |
24-06-06 | 2.57 | -2.10% | 4,628 |
Delayed Quote Nyse, June 12, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.73% | 99.06M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- ARMP Stock